Literature DB >> 19567529

X-chromosome gene dosage and the risk of diabetes in Turner syndrome.

Vladimir K Bakalov1, Clara Cheng, Jian Zhou, Carolyn A Bondy.   

Abstract

BACKGROUND: Turner syndrome (TS) is caused by the absence or fragmentation of the second sex chromosome. An increased risk of diabetes mellitus (DM) has consistently been noted, but the specific phenotype and genetic etiology of this trait are unknown.
METHODS: In a prospective study, we examined the prevalence of DM in adult participants in an intramural National Institutes of Health (NIH) TS study. Results were analyzed with respect to karyotype, age, body mass index (BMI), and autoimmune indices. Insulin sensitivity and secretion were compared in age- and BMI-matched euglycemic women with TS and healthy female controls. We compared gene expression profiles in lymphocytes from differentially affected TS groups.
RESULTS: Type 2 DM was present in 56 of 224 (25%) of the women with TS; type 1 DM was found in only one woman (<0.5%). DM was more prevalent among women with an isoXq chromosome compared to X monosomy (40.0 vs. 17.3%; P = 0.004). Euglycemic women with TS (n = 72; age, 33 +/- 12 yr; BMI, 23 +/- 3 kg/m(2)) had significantly higher glycemic and lower insulin responses to OGTT, with insulin sensitivity similar to controls. Gene expression profiles comparing 46,X,i(X)q vs. 45,X groups showed a significant increase in Xq transcripts and in potentially diabetogenic autosomal transcripts in the isoXq group.
CONCLUSION: Type 2 DM associated with deficient insulin release is significantly increased among women with monosomy for the X-chromosome but is increased even more among women with monosomy for Xp coupled with trisomy for Xq. These data suggest that haploinsufficiency for unknown Xp genes increases risk for DM and that excess dosage of Xq genes compounds the risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567529      PMCID: PMC2741724          DOI: 10.1210/jc.2009-0384

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Sox9 coordinates a transcriptional network in pancreatic progenitor cells.

Authors:  F C Lynn; S B Smith; M E Wilson; K Y Yang; N Nekrep; M S German
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

3.  Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein.

Authors:  Julia E Ostberg; M Javad Hosseinzadeh Attar; Vidya Mohamed-Ali; Gerard S Conway
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

Review 4.  SHOX: growth, Léri-Weill and Turner syndromes.

Authors:  R J Blaschke; G A Rappold
Journal:  Trends Endocrinol Metab       Date:  2000-08       Impact factor: 12.015

5.  Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome.

Authors:  Burak Salgin; Rakesh Amin; Kevin Yuen; Rachel M Williams; Peter Murgatroyd; David B Dunger
Journal:  Horm Res       Date:  2006-01-10

6.  The abnormalities of carbohydrate metabolism in Turner syndrome: analysis of risk factors associated with impaired glucose tolerance.

Authors:  In Kyoung Choi; Duk Hee Kim; Ho-Seong Kim
Journal:  Eur J Pediatr       Date:  2005-04-23       Impact factor: 3.183

7.  Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.

Authors:  Nicole Wooten; Vladimir K Bakalov; Suvimol Hill; Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

8.  Long-term safety of recombinant human growth hormone in turner syndrome.

Authors:  Katrina Bolar; Andrew R Hoffman; Thomas Maneatis; Barbara Lippe
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

9.  Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.

Authors:  Bernadette Neve; Martin E Fernandez-Zapico; Vered Ashkenazi-Katalan; Christian Dina; Yasmin H Hamid; Erik Joly; Emmanuel Vaillant; Yamina Benmezroua; Emmanuelle Durand; Nicolas Bakaher; Valerie Delannoy; Martine Vaxillaire; Tiffany Cook; Geesje M Dallinga-Thie; Hans Jansen; Marie-Aline Charles; Karine Clément; Pilar Galan; Serge Hercberg; Nicole Helbecque; Guillaume Charpentier; Marc Prentki; Torben Hansen; Oluf Pedersen; Raul Urrutia; Danielle Melloul; Philippe Froguel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

10.  Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis.

Authors:  Clemens D Cohen; Maja T Lindenmeyer; Felix Eichinger; Alexander Hahn; Martin Seifert; Anton G Moll; Holger Schmid; Eva Kiss; Elisabeth Gröne; Hermann-Josef Gröne; Matthias Kretzler; Thomas Werner; Peter J Nelson
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

View more
  30 in total

Review 1.  Cardiovascular disease and primary ovarian insufficiency.

Authors:  Melissa Wellons
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency.

Authors:  Vladimir K Bakalov; Liat Gutin; Clara M Cheng; Jian Zhou; Puja Sheth; Kavita Shah; Sruthi Arepalli; Vien Vanderhoof; Lawrence M Nelson; Carolyn A Bondy
Journal:  J Autoimmun       Date:  2012-02-18       Impact factor: 7.094

Review 3.  Dynamics of diabetes and obesity: Epidemiological perspective.

Authors:  Annette Boles; Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-24       Impact factor: 5.187

4.  New insights on diabetes in Turner syndrome: results from an observational study in adulthood.

Authors:  Daniela Ibarra-Gasparini; Paola Altieri; Emanuela Scarano; Annamaria Perri; Antonio M Morselli-Labate; Uberto Pagotto; Laura Mazzanti; Renato Pasquali; Alessandra Gambineri
Journal:  Endocrine       Date:  2017-06-07       Impact factor: 3.633

5.  The association with Turner syndrome significantly affects the course of Hashimoto's thyroiditis in children, irrespective of karyotype.

Authors:  Tommaso Aversa; Maria Francesca Messina; Laura Mazzanti; Mariacarolina Salerno; Alessandro Mussa; Maria Felicia Faienza; Emanuela Scarano; Filippo De Luca; Malgorzata Wasniewska
Journal:  Endocrine       Date:  2014-12-27       Impact factor: 3.633

Review 6.  X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene?

Authors:  Stéphanie Olivier-Van Stichelen; Lara K Abramowitz; John A Hanover
Journal:  Biochem Biophys Res Commun       Date:  2014-06-21       Impact factor: 3.575

7.  Network-based analysis of key regulatory genes implicated in Type 2 Diabetes Mellitus and Recurrent Miscarriages in Turner Syndrome.

Authors:  Anam Farooqui; Alaa Alhazmi; Shafiul Haque; Naaila Tamkeen; Mahboubeh Mehmankhah; Safia Tazyeen; Sher Ali; Romana Ishrat
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

8.  Metabolic impact of sex chromosomes.

Authors:  Jenny C Link; Xuqi Chen; Arthur P Arnold; Karen Reue
Journal:  Adipocyte       Date:  2013-04-01       Impact factor: 4.534

Review 9.  Sex and the kidneys: current understanding and research opportunities.

Authors:  C Noel Bairey Merz; Laura M Dember; Julie R Ingelfinger; Amanda Vinson; Joel Neugarten; Kathryn L Sandberg; Jennifer C Sullivan; Christine Maric-Bilkan; Tracy L Rankin; Paul L Kimmel; Robert A Star
Journal:  Nat Rev Nephrol       Date:  2019-10-04       Impact factor: 28.314

10.  Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency.

Authors:  Christopher E Gibson; Kara E Boodhansingh; Changhong Li; Laura Conlin; Pan Chen; Susan A Becker; Tricia Bhatti; Vaneeta Bamba; N Scott Adzick; Diva D De Leon; Arupa Ganguly; Charles A Stanley
Journal:  Horm Res Paediatr       Date:  2018-06-14       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.